| 000 | 01359 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517063842.0 | ||
| 264 | 0 | _c20160310 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/CP202426 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOkada, Naoto | |
| 245 | 0 | 0 |
_aIfosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cJan 2016 |
||
| 300 |
_a58-61 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C9 Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEtoposide _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xpharmacology |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aWarfarin _xpharmacology |
| 700 | 1 | _aWatanabe, Hiroyoshi | |
| 700 | 1 | _aKagami, Shoji | |
| 700 | 1 | _aIshizawa, Keisuke | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 54 _gno. 1 _gp. 58-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202426 _zAvailable from publisher's website |
| 999 |
_c25467049 _d25467049 |
||